Michael Kee-Ming Shu

1PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 08, 2024
Durable response in platinum refractory small cell carcinoma of the ovary hypercalcemic type treated with combination pembrolizumab, oral cyclophosphamide, and bevacizumab.

Michael Kee-Ming Shu, Elena Moses, Elizabeth Korangy

Pageof 1

Frequent Collaborators